KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 906 followers.

New article: KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway https://t.co/QpFPD9czwV #pancreaticcancer #oncology https://t.co/mcFjfButCY

New article: KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway https://t.co/xTUeyAcELG #lungcancer #oncology https://t.co/n2oJ9yGppt

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.